Skip to main content
NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ: NRXP · Real-Time Price · USD
2.950
-0.080 (-2.64%)
At close: Apr 28, 2026, 4:00 PM EDT
2.940
-0.010 (-0.34%)
Pre-market: Apr 29, 2026, 6:24 AM EDT

NRx Pharmaceuticals Revenue

In the year 2025, NRx Pharmaceuticals had annual revenue of $1.23M. NRx Pharmaceuticals had revenue of $983.00K in the quarter ending December 31, 2025.

Revenue (ttm)
$1.23M
Revenue Growth
n/a
P/S Ratio
79.55
Revenue / Employee
$42,241
Employees
29
Market Cap
97.45M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20251.23M--
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Q32 Bio 53.74M
Coya Therapeutics 7.95M
Rani Therapeutics Holdings 1.63M
Coeptis Therapeutics Holdings 1.36M
Inovio Pharmaceuticals 65.34K
Fractyl Health 3.00K
Revenue Rankings

NRXP News

More News